ARTICLE | Company News
Bayer exercises option for BiTE antibody
December 2, 2009 1:17 AM UTC
Bayer AG (Xetra:BAY) exercised its option to license exclusive, worldwide rights to a Bispecific T cell engager (BiTE) antibody from Micromet Inc. (NASDAQ:MITI) against an undisclosed solid tumor targ...